Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. af Vincent, A, Leite, M

Seronegative NMO: a sensitive AQP4 antibody test clarifies clinical features and next challenges. af Fujihara, K, Leite, M

Antibodies to aquaporin-1 are not present in neuromyelitis optica af Waters, P, Leite, M, Palace, J

Diagnostic use of autoantibodies in myasthenia gravis. af Leite, M, Waters, P, Vincent, A

The differential diagnoses of patients presenting with longitudinally extensive transverse myelitis: analysis of 76 cases af Kitley, J, Leite, M, Palace, J

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. af Palace, J, Leite, M, Nairne, A, Vincent, A

Use of mitoxantrone in neuromyelitis optica. af Kitley, J, Leite, M, Matthews, L, Palace, J

The differential diagnosis of longitudinally extensive transverse myelitis. af Kitley, J, Leite, M, George, J, Palace, J

To start immune therapy or not? An unusual presentation of longitudinally extensive transverse myelitis with pyrexia af Rounis, E, Leite, M, Pretorius, P, Sen, A

LONGITUDINALLY EXTENSIVE TRANSVERSE MYELITIS: A VARIETY OF CAUSES SEEN WITHIN THE NATIONAL NEUROMYELITIS OPTICA SERVICE af Kitley, J, George, J, Leite, M, Palace, J

NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro af Jarius, S, Jacob, S, Leite, M, Waters, P, Vincent, A

A practical guide to the treatment of neuromyelitis optica. af Palace, J, Leite, M, Leite, I, Jacob, A

Analogue closed-loop optogenetic modulation of hippocampal pyramidal cells dissociates gamma frequency and amplitude af Nicholson, E, Kuzmin, D, Leite, M, Akam, T, Kullmann, D

‘Less contented as a person’: preliminary data from the LGI1-QoL study af Binks, S, Jacob, S, Maddison, P, Coebergh, J, Leite, M, Irani, S

Generation of aquaporin-4 autoantibodies from B cells of patients with neuromyelitis optica: towards precision medicine af Irani, S, Makuch, M, Leite, M, Waters, P, Wilson, R

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials. af Kitley, J, Leite, M, Elsone, L, Jacob, A, Palace, J

Sequential voltage-gated potassium channel and aquaporin-4 antibodies in a patient with seropositive myasthenia gravis, limbic encephalitis and neuromyelitis optica af Jacobson, L, Waters, P, Leite, M, Vincent, A, Buckley, C

EXPANDING THE PHENOTYPIC SPECTRUM OF PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY AND MYOCLONUS SYNDROME (PERMS) ASSOCIATED WITH GLYCINE RECEPTOR ANTIBODY: CLINICAL AND LABORATORY S... af Leite, M, Waters, P, Carvajal, A, Woodhall, M, Vincent, A

A case of glycine-receptor antibody-associated encephalomyelitis with rigidity and myoclonus (PERM): clinical course, treatment and CSF findings. af Piotrowicz, A, Thümen, A, Leite, M, Vincent, A, Moser, A

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica af Waters, P, Palace, J, Leite, M, Woodhall, M, Vincent, A